WHO Prequalifies First Antigen-Based TB Skin Test: A Milestone for Detection of TB Infection Globally
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Micro Labs’ pediatric dispersible dolutegravir tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Shanghai Desano’s emtricitabine/tenofovir tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Ipca’s primaquine tabl prequalified
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Active Pharmaceutical Ingredient (API) Prequalified
Dolutegravir sodium (WHOAPI-445) manufactured by Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd.
39th Invitation of Active Pharmaceutical Ingredients (APIs)
The following API was added:
23rd Invitation to Manufacturers and Suppliers of Medicinal Products for HIV Infections and Related Diseases to Submit an Expression of Interest (EOI) for Product Evaluation to the WHO Prequalification Unit
The 23rd EOI for HIV/AIDS Products includes the addition of a co-pack of Cabotegravir extended-release intramuscular injection + Rilpivirine extended release intramuscular injection, as well as the
WHO prequalifies the first triple diagnostic test
WHO has granted the first prequalification listing of a bundle of three diagnostics tests to be used for pregnant women for the qualitative detection of HIV, Hepatitis B Surface Antigen, and Trepon